Conferences
ASCO GU 2025: Beneath the Surface: Unleashing the Potential of ctDNA across the Spectrum of Urothelial Carcinoma
February 15, 2025
ASCO GU 2025: Datopotamab Deruxtecan (Dato-DXd) in Locally Advanced/metastatic Urothelial Cancer: Updated Results from the Phase 1 TROPION PanTumor01 Study
February 15, 2025